Brief: Neuronetics - Cash And Cash Equivalents Were $35.8 Million As Of Sept. 30, 2023

Neuronetics

07/11/2023 12:35

Nov 7 (Reuters) - Neuronetics Inc  STIM.O :
    * CASH AND CASH EQUIVALENTS WERE $35.8 MILLION AS OF
SEPTEMBER 30,
2023
    * FOR FULL YEAR 2023, COMPANY NOW EXPECTS TOTAL REVENUE TO
BE
BETWEEN $70.0 MILLION AND $72.0 MILLION
    * FOR Q4 OF 2023, COMPANY EXPECTS TOTAL REVENUE BETWEEN
$19.0
MILLION AND $21.0 MILLION.
    * QTRLY LOSS PER SHARE $0.33
    * Q3 EARNINGS PER SHARE VIEW $-0.31 -- LSEG IBES DATA
    * Q4 REVENUE VIEW $19.8 MILLION -- LSEG IBES DATA
    * FY2023 REVENUE VIEW $70.5 MILLION -- LSEG IBES DATA

Source text for Eikon:  ID:nGNX9N5FwV 
Further company coverage:  STIM.O 

 ((Reuters.Briefs@thomsonreuters.com;))